Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis

British Journal of Haematology

Volumn 118, Issue 1, 2002, Pages 313-319

  Ohga, Shouichi ^a,b   Ohara, Akira ^a   Hibi, Shigeyoshi ^a   Kojima, Seiji ^a   Bessho, Fumio ^a   Tsuchiya, Shigeru ^a   Ohshima, Yukio ^a   Yoshida, Nobuyuki ^a   Kashii, Yoshifumi ^a   Nishimura, Shinichiro ^a   Kawakami, Kiyoshi ^a   Nishikawa, Kenichi ^a   Tsukimoto, Ichiro ^a  

^a Japanese Society of Paediatric Haematology   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Aplastic anaemia; Clonal disease; Cytogenetic abnormality; Immunosuppressive therapy; Myelodysplastic syndrome

Indexed keywords

CYCLOSPORIN; THYMOCYTE ANTIBODY;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHILD; CHROMOSOME 13; CHROMOSOME 20; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME ADDITION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REMISSION; ROBERTSONIAN CHROMOSOME TRANSLOCATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0036066262     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03582.x     Document Type: Article

References (32)

1. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia
2. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia
3. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders
4. Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy
5. Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders
6. Abnormal cytogenetic clones in patients with aplastic anaemia: Response to immunosuppressive therapy
7. Trisomy 6 associated with aplastic anemia
8. International scoring system for evaluating prognosis in myelodysplastic syndromes
9. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow
10. Clonal hematopoiesis in patients with acquired aplastic anemia
11. Bone marrow cytogenetic abnormalities of aplastic anemia
12. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia
13. Trisomy 6 is the hallmark of a dysplastic clone in bone marrow aplasia
14. Trisomy 8 may not be related to the pathogenesis of myelodysplastic syndromes: Disappearance of trisomy 8 in a patient with refractory anemia without haematological improvement
15. Cytogenetic abnormalities in patients with severe aplastic anemia
16. Anti-thymocyte globulin for patients with myelodysplastic syndrome
17. Haematological response of patients with myelodysplastic syndrome to anti-thymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vβ profiles
18. Trisomy 6: A recurring cytogenetic abnormality associated with marrow hypoplasia
19. Myelodys-plastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia
20. Expansion of trisomy 8 and Sweet syndrome in a prolonged course of childhood aplastic anemia
21. Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy
22. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults
23. Trisomy 14: A recurring cytogenetic abnormality associated with myeloid disorders
24. Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia
25. Malignant tumors occurring after treatment of aplastic anemia
26. Late clonal diseases of treated aplastic anemia
27. Disappearance of cytogenetic abnormalities induced by cyclosporine therapy in a case of aplastic anemia
28. Late haematological complications in severe aplastic anaemia
29. Clonal remission in aplastic anemia after treatment with antithymocyte globulin
30. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated
31. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia
32. The pathophysiology of acquired aplastic anemia